3-(1-(tert-Butoxycarbonyl)azetidin-3-yl)cyclobutanecarboxylic acid
95%
- Product Code: 64306
CAS:
1989659-47-3
| Molecular Weight: | 255.3106 g./mol | Molecular Formula: | C₁₃H₂₁NO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30342776 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development, where it serves as a key intermediate in the synthesis of more complex molecules. Its structure, featuring both azetidine and cyclobutane rings, makes it valuable for constructing pharmacologically active compounds, particularly those targeting central nervous system disorders. The tert-butoxycarbonyl (Boc) protecting group enhances its stability during chemical reactions, allowing for selective modifications. Researchers often employ it in the preparation of drug candidates, especially in the development of modulators for receptors or enzymes involved in neurological pathways. Its application is critical in optimizing the pharmacokinetic and pharmacodynamic properties of potential therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £529.24 |
+
-
|
| 0.250 | 10-20 days | £1,129.72 |
+
-
|
3-(1-(tert-Butoxycarbonyl)azetidin-3-yl)cyclobutanecarboxylic acid
This compound is primarily utilized in the field of pharmaceutical research and development, where it serves as a key intermediate in the synthesis of more complex molecules. Its structure, featuring both azetidine and cyclobutane rings, makes it valuable for constructing pharmacologically active compounds, particularly those targeting central nervous system disorders. The tert-butoxycarbonyl (Boc) protecting group enhances its stability during chemical reactions, allowing for selective modifications. Researchers often employ it in the preparation of drug candidates, especially in the development of modulators for receptors or enzymes involved in neurological pathways. Its application is critical in optimizing the pharmacokinetic and pharmacodynamic properties of potential therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :